Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 883 (ZNF883) is a protein-coding gene predicted to function as a transcription factor, specifically enabling sequence-specific DNA binding and regulation of transcription by RNA polymerase II[1][2][10][12]. It belongs to the C2H2-type zinc finger family and is predicted to be located in the nucleus, where it may participate in transcriptional regulation[2][4][6][12]. While the specific biological or pathological roles of ZNF883 in human disease are not well characterized, it shares structural features with other zinc finger transcription factors that generally play roles in modulating gene expression. No known drugs, drug mechanisms, biomarkers, or significant safety concerns have been attributed to this gene to date[11][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 883 (ZNF883).